USFDA has completed the inspection without any observations.
The inspection took place from October 17 to October 21, 2022.
Alembic Pharmaceuticals Ltd. is a worldwide pharmaceutical firm based in Vadodara, India. It is engaged in the production of pharmaceutical goods, pharmaceutical ingredients, and pharmaceutical intermediates. In India, it is also considered as a market leader in the macrolides sector of anti-infective medications.
At around 9.26 AM, Alembic Pharmaceuticals was trading at Rs547.10 down by 0.28% from its previous closing of Rs548.65 on the BSE. The scrip opened at Rs550.85 and touched intraday high and low of Rs557.95 and Rs547.10 respectively.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
